ENHO and metabolic dysfunction-associated steatotic liver disease: Human data demonstrated that patients with NAFLD had marked endothelial NO synthase (eNOS) dysfunction and animal data demonstrated that eNOS deficiency exacerbated the early stages of NAFLD [21, 22]. Adropin was first identified in the liver and brain tissues of rats [21].